Group items tagged

This Funding Opportunity Announcement (FOA) solicits applications from institutions/organizations to participate as "Minority/Underserved Community Sites" for the National Cancer Institute (NCI)-supported Community Oncology Research Program (NCORP). NCORP is a community-based research network that: Designs and conducts clinical trials and other human subject studies for adults and children in cancer control, prevention, screening, and care delivery, as well as quality-of-life studies embedded within treatment trials; Incorporates the needs of diverse populations such as, adolescents and young adults (AYAs), and the elderly; racial and ethnic minorities; sexual and gender minorities; and rural residents into studies and takes steps to enhance participation of these groups; Enhances patient and provider access to treatment and imaging trials conducted under the National Clinical Trials Network (NCTN); Integrates cancer disparities research within the community network. NCORP consists of three components each with its own FOA: NCORP Research Bases; NCORP Community Sites; and NCORP Minority/Underserved Community Sites (covered by this FOA). The NCORP Minority/Underserved Community Sites will accrue diverse patients/participants to NCI-approved, cancer control, prevention, and care delivery research studies designed by NCI's NCORP Research Bases as well as treatment trials within the National Clinical Trials Network Groups (NCTN).

The New Scholars Program supports projects to help early- to mid-career women scientists balance family responsibilities with demanding academic careers. New Scholars seeks to actively address the attrition rate of talented women scientists caused by work-life balance issues.

The L'Oréal USA For Women in Science fellowship program is a national awards program that annually recognizes and rewards five U.S.-based women researchers at the beginning of their scientific careers. Recipients receive up to $60,000 each that they must put towards their postdoctoral research. The program's partner, AAAS, manages the peer-review process. Launched in 2003 as the U.S. Fellowships component of the L'Oréal-UNESCO For Women in Science International Fellowship program, the program aim to: Raise awareness of the contribution of women to the sciences Identify exceptional female researchers in the U.S. to serve as role models for younger generations An inter-disciplinary panel of scientists reviews all applications submitted. The top candidates chosen by the review panel are then forwarded for final selection to a distinguished Jury of career scientists and former North American L'ORÉAL-UNESCO For Women in Science Laureates. The Jury seeks candidates with exceptional academic records and intellectual merit, clearly articulated research proposals with the potential for scientific advancement and outstanding letters of recommendation from advisers. New to the program this year, applicants will also be evaluated in part on their commitment to supporting women and girls in science.

OCRFA's Woman to Woman is a peer-to-peer support program for women with gynecologic cancers. The programs pairs gynecologic cancer patients with trained survivor volunteers who provide one-on-one emotional support and mentoring to women when they need it most. From the moment of diagnosis through the end of treatment, Woman to Woman survivor volunteers have helped hundreds of women and their families cope with gynecologic cancer.

Woman to Woman, a program of the Ovarian Cancer Research Fund Alliance, pairs gynecologic cancer patients with trained survivor-volunteers who provide one-on-one emotional support and mentoring to women when they need it most. From the moment of diagnosis through the end of treatment, Woman to Woman survivor-volunteers have helped hundreds of women and their families cope with gynecologic cancer. Through the program, one-year grants of either $60,000 (for hospital-based programs) or $30,000 (for community-based organizations) will be awarded to institutions with a large volume of gynecologic cancer patients and a need to provide this type of support to patients. Grants are provided to cover the cost of a part-time program coordinator's salary (can be a new hire or a reassignment), program costs, and a patient fund (no indirect costs allowed). It is expected that each Woman to Woman program will become self-sustaining after the first year. OCRFA will provide all program materials for patients, as well as technical assistance and support, for the life of the program (even after the end of the grant period). Institutions and organizations also will have access to a dedicated section of the Woman to Woman website (under construction) featuring tools designed to assist them in the development and administration of new programs.

The Tell Every Amazing Lady About Ovarian Cancer Louisa M. McGregor Ovarian Cancer Foundation, also known as T.E.A.L.®, is accepting applications for its 2018 Medical Research Program. The program, which aids in the advancement of ovarian cancer treatment research and the need for a screening test, offers funding in support of ovarian cancer research studies that are deemed to be most aligned with T.E.A.L.®'s mission by the organization's board of directors and a scientific advisory board. This year, the program has special interest in research related to the p53 gene, although it will accept proposals for other research related to ovarian cancer. In 2018, T.E.A.L.® will award one-year grants of up to $60,000. Project costs must be thoroughly outlined in the budget portion of the application, and grants cannot be applied to indirect costs or PI salary. All applicants must be affiliated with a non-for-profit institution in the United States and must complete all sections of the online application found here: https://goo.gl/forms/Bvk0RrwpnnQbYIjC3. (Applications from for profit organizations or federal or state government agencies will not be considered.)

The purpose of the Funding Opportunity Announcement (FOA) is to support pilot research projects using a "Traceback" approach to genetic testing women with a personal or family history of ovarian cancer and reaching out to family members to identify unaffected individuals at increased risk for cancer in different clinical contexts and communities, including racially/ethnically diverse populations.